Guitao Wang

Company: Coherent Biopharma

Job title: President of Research & Development

Seminars:

Bi-XDC Platform: A Targeted Super Chemo-/RadioPharma Therapy & Beyond 1:00 pm

TAG-Display: a high throughput ligand discovery platform for bi-XDC Research update of bi-XDCs delivering traditional toxin payload Exploration of bi-XDCs delivering novel payload beyond toxin, e.g. PROTACs radioisotopes, and immune-regulatorsRead more

day: Conference Day 2